Tersera Drug Patent Portfolio

Tersera owns 5 orange book drugs protected by 24 US patents with Qmiiz Odt having the least patent protection, holding only 1 patent. And Varubi with maximum patent protection, holding 10 patents. Given below is the list of Tersera's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US9101615 Intravenous formulations of neurokinin-1 antagonists 14 Jul, 2032
Active
US7709493 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use 28 Feb, 2031
Active
US8193204 Solid forms of (S)-ethyl 2-amino-3-(4-(2-amino-6-((R)-1- (4-chloro-2-(3-methyl-1H-pyrazol-1-YL)phenyl)2,2,2-trifluoroethoxy)-pyrimidin-4-YL)phenyl)propanoate and methods of their use 27 Feb, 2031
Active
US8545879 Fast disintegrating compositions of meloxicam 31 Aug, 2030
Active
US8361500 Tablet formulations containing 8-[{1-(3,5-Bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one salts and tablets made therefrom 09 Oct, 2029
Active
US8470842 Hydrochloride salts of 8-[{1-(3,5-Bis-trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and preparation process therefor 18 Jan, 2029
Active
US8653094 Solid forms of (S)-ethyl 2-amino-3-(4-(2-amino-6-((R)-1-(4-chloro-2-(3-methyl-1H-pyrazol-1-yl)phenyl)-2,2,2-trifluoroethoxy)-pyrimidin-4-yl)phenyl)propanoate and methods of their use 19 Dec, 2028
Active
US7049320 NK1 antagonists 19 Aug, 2028
Active
US7553840 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use 11 Dec, 2027
Active
US7968559 Methods of using 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds 11 Dec, 2027
Active
US7563801 Pharmaceutical formulations: salts of 8-[{1-(3,5-Bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and treatment methods using the same 04 Apr, 2027
Active
US7981905 Pharmaceutical formulations: salts of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-Ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and treatment methods using the same 04 Apr, 2027
Active
US8178550 Hydrochloride salts of 8-[{1-(3,5-Bis-(trifluoromethyl)phenyl)-ethoxy)-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and preparation process therefor 04 Apr, 2027
Active
US8404702 Pharmaceutical formulations:salts of 8-[1-3,5-bis-(trifluoromethyl)phenyl)-ethoxymethyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and treatment methods using the same 04 Apr, 2027
Active
US8653033 Method for administering omega-conopeptide 01 Oct, 2024 Expired
US8765680 Method for administering omega-conopeptide 01 Oct, 2024 Expired
US9707270 Method for administering ω-conopeptide 01 Oct, 2024 Expired
US7049230 Method of forming a contact plug in a semiconductor device 08 Dec, 2023 Expired
US8796299 NK1 antagonists 17 Dec, 2022 Expired
US7118552 Automatically operable safety shield system for syringes 13 Apr, 2022 Expired
US7220247 Automatically operable safety shield system for syringes 09 Apr, 2022 Expired
US7500964 Automatically operable safety shield system for syringes 26 Feb, 2021 Expired
US5364842 Method of producing analgesia 30 Dec, 2016 Expired
US5795864 Stable omega conopetide formulations 27 Jun, 2015 Expired


Given below is the list of recent legal activities going on the following drug patents of Tersera.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 12th Year, Large Entity 22 Nov, 2023 US8193204
Payment of Maintenance Fee, 12th Year, Large Entity 15 Nov, 2023 US8178550
Payment of Maintenance Fee, 8th Year, Large Entity 13 Feb, 2023 US9101615
Payment of Maintenance Fee, 12th Year, Large Entity 19 Jan, 2023 US7981905
Payment of Maintenance Fee, 12th Year, Large Entity 14 Dec, 2022 US7968559
Mail Pub Notice re 312 amendment 01 Mar, 2022 US7709493
Email Notification 01 Mar, 2022 US7709493
POST ISSUE OTHER COMMUNICATION TO APPLICANT- CERTIFICATE OF CORRECTION 25 Feb, 2022 US7709493
Post Issue Communication - Certificate of Correction Denied 25 Feb, 2022 US7709493
Payment of Maintenance Fee, 8th Year, Large Entity 07 Feb, 2022 US8796299
Payment of Maintenance Fee, 8th Year, Large Entity 15 Dec, 2021 US8765680
Patent Term Extension Certificate 06 Dec, 2021 US7709493
Patent Term Extension Certificate 19 Nov, 2021 US7049320
Change in Power of Attorney (May Include Associate POA) 27 Oct, 2021 US8193204
Email Notification 27 Oct, 2021 US8193204


Tersera Drug Patents' Oppositions Filed in EPO

Tersera drug patents have faced multiple oppositions in the European Patent Office. The earliest opposition was filed on Mar 08, 2017, by Teva Pharmaceutical Industries Ltd. This opposition was filed on patent number EP07774640A. Click below to reveal the latest opposition data.


Application Filing Date Opposition Party Legal Status
Patent litigations
EP07774640A Mar, 2017 Teva Pharmaceutical Industries Ltd Revoked


Tersera's Family Patents

Tersera drugs have patent protection in a total of 44 countries. It's US patent count contributes only to 22.1% of its total global patent coverage. 18 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click below to unlock the full patent family tree.

Family Patents



Tersera Drug List

Given below is the complete list of Tersera's drugs and the patents protecting them.


1. Prialt

Prialt is protected by 5 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US8653033 Method for administering omega-conopeptide 01 Oct, 2024
(13 days ago)
Expired
US8765680 Method for administering omega-conopeptide 01 Oct, 2024
(13 days ago)
Expired
US9707270 Method for administering ω-conopeptide 01 Oct, 2024
(13 days ago)
Expired
US5364842 Method of producing analgesia 30 Dec, 2016
(7 years ago)
Expired
US5795864 Stable omega conopetide formulations 27 Jun, 2015
(9 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Prialt's drug page


2. Qmiiz Odt

Qmiiz Odt is protected by 1 patent, which is still active. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US8545879 Fast disintegrating compositions of meloxicam 31 Aug, 2030
(5 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Qmiiz Odt's drug page


3. Varubi

Varubi is protected by 10 patents, out of which 2 have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US9101615 Intravenous formulations of neurokinin-1 antagonists 14 Jul, 2032
(7 years from now)
Active
US8361500 Tablet formulations containing 8-[{1-(3,5-Bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one salts and tablets made therefrom 09 Oct, 2029
(4 years from now)
Active
US8470842 Hydrochloride salts of 8-[{1-(3,5-Bis-trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and preparation process therefor 18 Jan, 2029
(4 years from now)
Active
US7049320 NK1 antagonists 19 Aug, 2028
(3 years from now)
Active
US7563801 Pharmaceutical formulations: salts of 8-[{1-(3,5-Bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and treatment methods using the same 04 Apr, 2027
(2 years from now)
Active
US7981905 Pharmaceutical formulations: salts of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-Ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and treatment methods using the same 04 Apr, 2027
(2 years from now)
Active
US8178550 Hydrochloride salts of 8-[{1-(3,5-Bis-(trifluoromethyl)phenyl)-ethoxy)-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and preparation process therefor 04 Apr, 2027
(2 years from now)
Active
US8404702 Pharmaceutical formulations:salts of 8-[1-3,5-bis-(trifluoromethyl)phenyl)-ethoxymethyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and treatment methods using the same 04 Apr, 2027
(2 years from now)
Active
US7049230 Method of forming a contact plug in a semiconductor device 08 Dec, 2023
(10 months ago)
Expired
US8796299 NK1 antagonists 17 Dec, 2022
(1 year, 9 months ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Varubi's drug page


4. Xermelo

Xermelo is protected by 5 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US7709493 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use 28 Feb, 2031
(6 years from now)
Active
US8193204 Solid forms of (S)-ethyl 2-amino-3-(4-(2-amino-6-((R)-1- (4-chloro-2-(3-methyl-1H-pyrazol-1-YL)phenyl)2,2,2-trifluoroethoxy)-pyrimidin-4-YL)phenyl)propanoate and methods of their use 27 Feb, 2031
(6 years from now)
Active
US8653094 Solid forms of (S)-ethyl 2-amino-3-(4-(2-amino-6-((R)-1-(4-chloro-2-(3-methyl-1H-pyrazol-1-yl)phenyl)-2,2,2-trifluoroethoxy)-pyrimidin-4-yl)phenyl)propanoate and methods of their use 19 Dec, 2028
(4 years from now)
Active
US7553840 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use 11 Dec, 2027
(3 years from now)
Active
US7968559 Methods of using 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds 11 Dec, 2027
(3 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Xermelo's drug page


5. Zoladex

Zoladex is protected by 3 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US7118552 Automatically operable safety shield system for syringes 13 Apr, 2022
(2 years ago)
Expired
US7220247 Automatically operable safety shield system for syringes 09 Apr, 2022
(2 years ago)
Expired
US7500964 Automatically operable safety shield system for syringes 26 Feb, 2021
(3 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Zoladex's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List